Pituitary Hormone Excess Flashcards

1
Q

Effect of estrogen on prolactin

A

Estrogen also promotes prolactin release by reducing DA secretion, reducing sensitivity to DA, and increasing sensitivity to TRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does somatostatin inhibit?

A

GH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does prolactin inhibit?

A

GnRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What stimulated prolactin?

A

TRH and estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

7 physiologic causes of hyperprolacinemia

How high are levels?

A

Pregnancy, lactation, nipple stimulation, REM sleep, stress, sex, exercise
Usually less than 50 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 pharmacologic causes of hyperprolactinemia

How high are levels?

A

DA receptor blocker, antidepressants, estrogen

Usually less than 100 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

5 pathologic cause sof hyperprolactinemia

A

Prolactinoma, pituitary stalk disruption, primary hypothyroidism (high TRH), renal failure, intercostal nerve stimulation / chest wall injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prolactin levels in micro / macro adenomas

Size

A

•Microadenomas (200 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treating prolactinomas (5)

A
  • DA agonist is 1st line – bromocriptine or cabergoline. 90% of tumors respond
  • Surgery / radiation is reserved for refractory cases.
  • Others
  • Oral contraceptives replace back estrogen for women, and allow endometrial shedding via progestin. Does not treat the galactorrhea.
  • Thyroid hormone if due to primary hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What stimulates somatostatin release?

A

High GH and GHRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effects of GH (6)

A
  • Primary function in kids is linear growth. Kids / teens secrete more GH than adults.
  • In all people, it increases protein synthesis, increases lipolysis, and decreases carb utilization. Prevents protein breakdown, which aids in growth. Creates insulin resistance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of IGF1 (3)

A

IGF1 acts similarly to insulin: increases glucose uptake peripherally, decreases hepatic glucose output, and decreases lipolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3 counter regulatory functions of GH

A

Increases insulin resistance, decreases peripheral glucose utilization, and increases hepatic glucose output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4 physiologic causes of high GH

A

Stress, exercise, REM sleep, fasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

4 pharmacologic causes of high GH

A

Insulin-induced hypoglycemia, Norepi, clonidine (alpha 2 agonist for HTN), estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

6 pathologic causes of high GH

A

Pituitary adenoma (most common), ectopic GHRH tumor, anorexia, hepatic / renal failure, cachexia

17
Q

Glucose effects on GH

A

Hypoglycemia stimulates GH.

Hyperglycemia inhibits GH.

18
Q

Metabolic consequences of high GH (7)

A

HTN, diabetes, hypertriglyceridemia, hypercalciuria, heart disease, sleep apnea, colon polyps / cancer.

19
Q

Diagnosing GH excess

A
  • Elevated IGF1 is best screening test
  • Gold standard is glucose tolerance test. Normal response is suppression of GH to less than 1 ng/mL 1-2 hrs after ingesting 75g glucose. Pxs w/ excess fail to suppress GH.
  • Next step is to localize the tumor w/ imaging.
20
Q

Treating GH excess: 3 main types

A
  • 1st line therapy is transsphenoidal surgery (TSS).
  • Drugs are for pxs w/ persistent GH after TSS.
  • Somatostatin analogs – octreotide, lanreotide, pasireotide
  • DA agonists – bromocriptine, cabergoline.
  • GH receptor antagonists – Pegvisomant
  • Radiation is reserved for pxs refractory to surgery and drugs.
21
Q

3 somatostatin analogs

Mechanism

A
  • Octreotide, lanreotide, pasireotide

* Mechanism - Inhibit GH secretion, and thus decrease IGF1 levels

22
Q

Pegvisomant
Type of drug
Mechanism
Change in GH and IGF1 level

A
  • GH receptor antagonist
  • Mechanism - Competitive inhibition
  • IGF1 production decreases
  • GH levels may rise due to lack of negative feedback.